$ISPR
Ispire Technology Inc. Stock $ispr

$ispr Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121390023086406 Filed on November 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2022 Q3
Revenue	$42.86M	$32.63M	$26.94M
YoY Change	59.09%	-62.96%
Cost Of Revenue	$35.98M	$26.00M	$22.15M
YoY Change	62.41%	-65.23%
Gross Profit	$6.888M	$6.625M	$4.792M
YoY Change	43.74%	-50.21%
Gross Profit Margin	16.07%	20.3%	17.79%
Selling, General & Admin	$7.800M	$6.054M	$6.007M
YoY Change	29.84%	-57.65%
% of Gross Profit	113.23%	91.39%	125.35%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$29.12K	$25.78K	$6.556K
YoY Change	344.14%	173.67%
% of Gross Profit	0.42%	0.39%	0.14%
Operating Expenses	$7.800M	$6.054M	$6.007M
YoY Change	29.84%	-57.65%
Operating Profit	-$911.3K	$570.6K	-$1.215M
YoY Change	-24.99%	-157.71%
Interest Expense	$75.91K	-$389.4K
YoY Change		-715.94%
% of Operating Profit		-68.25%
Other Income/Expense, Net	-$43.20K	-$46.71K
YoY Change		-138.16%
Pretax Income	-$878.6K	$134.5K
YoY Change		-116.75%
Income Tax	$496.1K	$175.3K
% Of Pretax Income		130.35%
Net Earnings	-$1.375M	-$40.83K	-$2.002M
YoY Change	-31.33%	-97.82%
Net Earnings / Revenue	-3.21%	-0.13%	-7.43%
Basic Earnings Per Share	-$0.03		-$0.04
Diluted Earnings Per Share	-$0.03	$0.00	-$0.04
COMMON SHARES
Basic Shares Outstanding	54.86M shares	53.11M shares	50.00M shares
Diluted Shares Outstanding	54.25M shares		50.00M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$34.88M	$49.43M
YoY Change
Cash & Equivalents	$25.69M	$40.30M	$76.10M
Short-Term Investments	$9.193M	$9.134M
Other Short-Term Assets	$1.720M	$3.379M
YoY Change
Inventory	$5.609M	$7.472M
Prepaid Expenses
Receivables	$39.16M	$24.53M
Other Receivables	$244.9K	$127.6K
Total Short-Term Assets	$81.61M	$84.81M
YoY Change		-14.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.592M	$1.088M
YoY Change		854.29%
Goodwill
YoY Change
Intangibles	$255.7K	$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets	$6.793M	$5.882M
YoY Change		357.42%
Total Long-Term Assets	$6.793M	$5.882M
YoY Change		357.42%
TOTAL ASSETS
Total Short-Term Assets	$81.61M	$84.81M
Total Long-Term Assets	$6.793M	$5.882M
Total Assets	$88.41M	$90.69M
YoY Change		-9.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$50.68M	$1.274M
YoY Change		338.63%
Accrued Expenses	$17.31K	$35.85K
YoY Change		3.66%
Deferred Revenue	$1.290M	$988.6K
YoY Change		-40.88%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$54.01M	$55.96M
YoY Change		-37.1%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$3.388M	$3.356M
YoY Change
Total Long-Term Liabilities	$3.388M	$3.356M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$54.01M	$55.96M
Total Long-Term Liabilities	$3.388M	$3.356M
Total Liabilities	$57.39M	$59.32M
YoY Change		-33.33%
SHAREHOLDERS EQUITY
Retained Earnings	$4.473M	$5.848M
YoY Change		-51.05%
Common Stock	$5.427K	$5.422K
YoY Change		8.44%
Preferred Stock		$7.426M
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$31.01M	$31.37M	$9.758M
YoY Change
Total Liabilities & Shareholders Equity	$88.41M	$90.69M
YoY Change		-9.97%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2022 Q3
OPERATING ACTIVITIES
Net Income	-$1.375M	-$40.83K	-$2.002M
YoY Change	-31.33%	-97.82%
Depreciation, Depletion And Amortization	$29.12K	$25.78K	$6.556K
YoY Change	344.14%	173.67%
Cash From Operating Activities	-$12.88M	-$9.833M	$2.236M
YoY Change	-676.08%	-1383.96%
INVESTING ACTIVITIES
Capital Expenditures	$533.1K	$525.7K	$324.7K
YoY Change	64.17%	608.78%
Acquisitions
YoY Change
Other Investing Activities		$470.7K
YoY Change
Cash From Investing Activities	-$788.8K	-$55.00K	-$324.7K
YoY Change	142.89%	-25.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$945.5K	26.15M	-$291.4K
YoY Change	224.52%	-3864.01%
NET CHANGE
Cash From Operating Activities	-$12.88M	-9.833M	$2.236M
Cash From Investing Activities	-$788.8K	-55.00K	-$324.7K
Cash From Financing Activities	-$945.5K	26.15M	-$291.4K
Net Change In Cash	-$14.61M	16.26M	$1.620M
YoY Change	-1002.28%	-519747.28%
FREE CASH FLOW
Cash From Operating Activities	-$12.88M	-$9.833M	$2.236M
Capital Expenditures	$533.1K	$525.7K	$324.7K
Free Cash Flow	-$13.41M	-$10.36M	$1.911M
YoY Change	-801.87%	-1597.64%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q3	dei	Document Type DocumentType	10-Q
CY2023Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q3	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023Q3	dei	Entity File Number EntityFileNumber	001-41680
CY2023Q3	dei	Entity Registrant Name EntityRegistrantName	Ispire Technology Inc.
CY2023Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	93-1869878
CY2023Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	19700 Magellan Drive
CY2023Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Angeles
CY2023Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90502
CY2023Q3	dei	City Area Code CityAreaCode	(310)
CY2023Q3	dei	Local Phone Number LocalPhoneNumber	742-9975
CY2023Q3	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2023Q3	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q3	dei	Trading Symbol TradingSymbol	ISPR
CY2023Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2023Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q3	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023Q3	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	54268992	shares
CY2022Q3	us-gaap	Revenues Revenues	26943050	usd
CY2023Q3	us-gaap	Revenues Revenues	42864647	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	22150947	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	35976355	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	4792103	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	6888292	usd
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1501156	usd
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1068663	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4505815	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6730902	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	6006971	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	7799565	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1214868	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-911273	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	510	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	72246	usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-500794	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3661	usd
CY2022Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-19201	usd
CY2023Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-43204	usd
CY2022Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-519485	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	32703	usd
CY2022Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-1734353	usd
CY2023Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-878570	usd
CY2022Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	267401	usd
CY2023Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	496045	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2001754	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1374615	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-6876	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	44463	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2008630	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1330152	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50000000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54246212	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	40300573	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25686052	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	24526262	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	39160751	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	7472108	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	5609028	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3378617	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1964822	usd
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments	9133707	usd
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	9192746	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	84811267	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	81613399	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1088131	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1592092	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	255650	usd
CY2023Q2	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	732334	usd
CY2023Q3	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	660282	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4061617	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4285182	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5882082	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6793206	usd
CY2023Q2	us-gaap	Assets Assets	90693349	usd
CY2023Q3	us-gaap	Assets Assets	88406605	usd
CY2023Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	1274391	usd
CY2023Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	170507	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	988556	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1290061	usd
CY2023Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	281361	usd
CY2023Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	273745	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	63853	usd
CY2023Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	559991	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	944525	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1207234	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	55962184	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	54006421	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3356232	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3387844	usd
CY2023Q2	us-gaap	Liabilities Liabilities	59318416	usd
CY2023Q3	us-gaap	Liabilities Liabilities	57394265	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	140000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	140000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54222420	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54222420	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	54268992	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54268992	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	5422	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	5427	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	ispr	Equity Reserve EquityReserve	641943	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	25685475	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	26011086	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-163768	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-119305	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	5847804	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	4473189	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	31374933	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	31012340	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	90693349	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	88406605	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	11766743	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2001754	usd
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	-6876	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	9758113	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	31374933	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1374615	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	641943	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	325616	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Translation Adjustment Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTranslationAdjustmentTaxPortionAttributableToParent	44463	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	31012340	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2001754	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1374615	usd
CY2022Q3	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	6553	usd
CY2023Q3	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	29161	usd
CY2022Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	256655	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	312938	usd
CY2023Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	225487	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	967559	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5917620	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	14710476	usd
CY2022Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4780043	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1863080	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	24810	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1603180	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	15442733	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2449276	usd
CY2022Q3	ispr	Increase Decrease In Contract Liabilities IncreaseDecreaseInContractLiabilities	-997912	usd
CY2023Q3	ispr	Increase Decrease In Contract Liabilities IncreaseDecreaseInContractLiabilities	281529	usd
CY2022Q3	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-13887	usd
CY2023Q3	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-124950	usd
CY2022Q3	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	265925	usd
CY2023Q3	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	496138	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2235840	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12880245	usd
CY2022Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	324747	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	533122	usd
CY2023Q3	ispr	Acquisition Of Intangible Assets AcquisitionOfIntangibleAssets	255650	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-324747	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-788772	usd
CY2022Q3	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	105752	usd
CY2023Q3	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	703322	usd
CY2022Q3	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	185600	usd
CY2023Q3	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	242182	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-291352	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-945504	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	1619741	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-14614521	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	74480651	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	40300573	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	76100392	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25686052	usd
CY2023Q3	us-gaap	Asset Acquisition Consideration Transferred Transaction Cost AssetAcquisitionConsiderationTransferredTransactionCost	100	myr
CY2023Q3	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	255650	usd
CY2023Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001948455
CY2023Q3	us-gaap	Derivative Net Assets Percentage DerivativeNetAssetsPercentage	0.003	pure
CY2023Q3	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates include allowance for doubtful accounts, the useful lives of property and equipment, impairment of long-lived assets, and deferred cost. Actual results could differ from those estimates.</p>
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	9192746	usd
CY2022Q3	us-gaap	Revenues Revenues	26943050	usd
CY2023Q3	us-gaap	Revenues Revenues	42864647	usd
CY2023Q3	ispr	Additions To Valuation Allowance Amount AdditionsToValuationAllowanceAmount	93022	usd
CY2023Q2	us-gaap	Tax Credit Carryforward Valuation Allowance TaxCreditCarryforwardValuationAllowance	4500444	usd
CY2023Q3	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Customer Concentration</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">For the three months ended September 30, 2022 and 2023, the Company’s major customers, who accounted for more than 10% of the Company’s consolidated revenue, were as follows:</p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Three months ended<br/> September 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td>Major Customers</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Customer A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">37</td><td style="width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">35</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Customer B</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: hidden-fact-57; font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">16</td><td style="text-align: left">%</td></tr> </table><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top"> <td style="width: 0.25in; text-align: left"></td><td>Represented less than 10% of consolidated revenue.</td> </tr></table>
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	40300573	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25686052	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	40300573	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25686052	usd
CY2023Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	26025068	usd
CY2023Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	40256685	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1498806	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1095934	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	24526262	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	39160751	usd
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	225487	usd
CY2022Q3	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	0	usd
CY2023Q3	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	628359	usd
CY2022Q2	ispr	Prepaid Inventories PrepaidInventories	3209413	usd
CY2023Q3	ispr	Prepaid Inventories PrepaidInventories	1555469	usd
CY2022Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	127595	usd
CY2023Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	244928	usd
CY2022Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	26974	usd
CY2023Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	98754	usd
CY2022Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	14635	usd
CY2023Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent	65671	usd
CY2022Q2	us-gaap	Other Assets OtherAssets	3378617	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	1964822	usd
CY2022Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	518854	usd
CY2023Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	813912	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	339155	usd
CY2023Q3	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	563132	usd
CY2022Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	309990	usd
CY2023Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	324077	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1167999	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1701121	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	79868	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	109029	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1088131	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1592092	usd
CY2022Q3	us-gaap	Depreciation Depreciation	6556	usd
CY2023Q3	us-gaap	Depreciation Depreciation	29118	usd
CY2023Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	988556	usd
CY2023Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1290061	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4061617	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4285182	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	944525	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1207234	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3356232	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3387844	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	4300757	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4595078	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee	2455000	shares
CY2023Q3	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	9.76
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1525895	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1549132	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1394839	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	806759	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5276625	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	681547	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4595078	usd
CY2022Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	274951	usd
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	278441	usd
CY2022Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	239429	usd
CY2023Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	309252	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2023Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.08	pure
CY2023Q3	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.08	pure
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	148197	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	233392	usd
CY2023Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	97314	usd
CY2023Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	20442	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	35850	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17313	usd
CY2023Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	2598	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	281361	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	273745	usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	50000	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2023Q3	ispr	Remaining Award Vesting Percentage RemainingAwardVestingPercentage	0.75	pure
CY2023Q3	ispr	Pro Rate Basis ProRateBasis	P36M
CY2022Q3	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	22304556	usd
CY2023Q3	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	23518413	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1734353	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-878570	usd
CY2023Q3	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	496045	usd
CY2023Q3	us-gaap	Income Tax Effects Allocated Directly To Equity Prior Period Adjustment IncomeTaxEffectsAllocatedDirectlyToEquityPriorPeriodAdjustment	63946	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	63853	usd
CY2023Q3	us-gaap	Deferred Tax Assets Regulatory Assets And Liabilities DeferredTaxAssetsRegulatoryAssetsAndLiabilities	4593466	usd
CY2023Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	3822280	usd
CY2023Q3	us-gaap	Tax Credit Carryforward Valuation Allowance TaxCreditCarryforwardValuationAllowance	4593466	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2455000	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	9.76
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.53
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2455000	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.76
CY2023Q3	ispr	Weighted Average Fair Value Per Option Outstanding And Exercisable Beginning Balance WeightedAverageFairValuePerOptionOutstandingAndExercisableBeginningBalance	5.53
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	0	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	0	usd
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	0	usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	505979	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.04197	pure
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.50	pure
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50000000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54246212	shares
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2023Q3	dei	Amendment Flag AmendmentFlag	false
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2001754	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1374615	usd
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50000000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54246212	shares
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
CY2023Q2	ispr	Equity Reserve EquityReserve		usd
CY2022Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2023Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent		usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2023Q2	ispr	Weighted Average Fair Value Per Option Outstanding And Exercisable Beginning Balance WeightedAverageFairValuePerOptionOutstandingAndExercisableBeginningBalance
CY2023Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice

Files In Submission

Name	View Source	Status
0001213900-23-086406-index-headers.html	Edgar Link	pending
0001213900-23-086406-index.html	Edgar Link	pending
0001213900-23-086406.txt	Edgar Link	pending
0001213900-23-086406-xbrl.zip	Edgar Link	pending
f10q0923ex31-1_ispiretech.htm	Edgar Link	pending
f10q0923ex31-2_ispiretech.htm	Edgar Link	pending
f10q0923ex32-1_ispiretech.htm	Edgar Link	pending
f10q0923_ispiretech.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
ispr-20230930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
ispr-20230930_cal.xml	Edgar Link	unprocessable
ispr-20230930_lab.xml	Edgar Link	unprocessable
ispr-20230930_def.xml	Edgar Link	unprocessable
ispr-20230930_pre.xml	Edgar Link	unprocessable
f10q0923_ispiretech_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ISPR
Ispire Technology Inc. Stock $ispr

2023 Q3 Form 10-Q Financial Statement

#000121390023086406 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ISPR Ispire Technology Inc. Stock $ispr

2023 Q3 Form 10-Q Financial Statement

#000121390023086406 Filed on November 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ISPR
Ispire Technology Inc. Stock $ispr